Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health”

1,166 pharma patents match "The United States of America, as represented by the Secretary, Department of Health" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,166
Index total 30,257
Page 20 / 49

Quick answer

This filtered view shows 1,166 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,166 results for “The United States of America, as represented by the Secretary, Department of Health” · 30,257 patents in full index Clear search

  1. US 10548970

    Human rotavirus G9P[6] strain and use as a vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted

  2. US 10543257

    Lentiviral vector for treating hemoglobin disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  3. US 10544392

    Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  4. US 10517890

    Triggering RNA interference with RNA-DNA and DNA-RNA nanoparticles

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  5. US 10519222

    Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  6. US 10512671

    IL-24 to treat inflammatory diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  7. US 10512673

    Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  8. US 10513521

    Compositions and methods for inhibiting BMP

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  9. US 10508106

    Bicyclic BET bromodomain inhibitors and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted

  10. US 10500269

    Human rotavirus vaccine strains and diagnostics

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  11. US 10500264

    Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  12. US 10500238

    Use of gram negative species to treat atopic dermatitis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  13. US 10501507

    Griffithsin mutants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  14. US 10485792

    Sustained release delivery systems for the prevention and treatment of head and neck cancers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted

  15. US 10485771

    Methods of regulating cannabinoid receptor activity-related disorders and diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted

  16. US 10480031

    Method for generating Retinal Pigment Epithelium (RPE) cells from Induced Pluripotent Stem Cells (IPSCs)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted

  17. US 10478415

    Ketone bodies to protect tissues from damage by ionizing radiation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted

  18. US 10471061

    Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted

  19. US 10472412

    Bispecific multivalent fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted

  20. US 10464970

    Compounds that bind to human immunodeficiency virus rev response element

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted

  21. US 10456461

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted

  22. US 10450372

    Anti-thyroglobulin T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  23. US 10434174

    Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted

  24. US 10428119

    Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.